ClinicalImpact™ Melanoma: Expert Guidance and Resources to Optimize Care Along the Treatment Continuum

Download this slideset to gain key insights on adjuvant therapy and best practice management of high-risk melanoma through the use of targeted therapy and immunotherapy

Ahmad Tarhini, MD, PhD Released: November 3, 2020

Download this slideset to gain key insights into current therapeutic strategies in advanced melanoma, including optimal approaches for managing CNS metastases.

Michael A. Davies, MD, PhD Released: November 3, 2020

Download this short summary slideset of key takeaways from a live CCO Webinar focused on current management of patients with high-risk resectable or metastatic melanoma.

Michael A. Davies, MD, PhD Ahmad Tarhini, MD, PhD Released: November 6, 2020

How do you choose among approved adjuvant therapies for BRAF V600E/K high-risk melanoma? Read my thoughts on factors to consider when selecting adjuvant targeted therapy for your patients.

Douglas B. Johnson, MD, MSCI Released: October 19, 2020

Here are my thoughts on key considerations when selecting frontline therapy for patients with metastatic melanoma, including when targeted therapy may be preferred over immunotherapy, factors that affect the selection of single-agent or combination immunotherapy, and when to discontinue immunotherapy.

Allison Betof Warner, MD, PhD Released: February 17, 2021

Experts answer frequently asked questions on the management of melanoma, including adjuvant therapy selection, considerations for frontline treatment, and biomarker testing.

Michael A. Davies, MD, PhD Ahmad Tarhini, MD, PhD Released: March 3, 2021

In this engaging and concise interactive module, gain insights on empowering patients with melanoma to be a central figure in their own care before, during, and after treatment.

Trish Brothers, BSN Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 2, 2021 Expired: No longer available for credit

In this engaging and concise interactive virtual presentation, learn how melanoma experts utilize biomarkers such as BRAF, NRAS, c-KIT, and PD-L1, to inform treatment decisions.

Evan J. Lipson, MD Megan Schollenberger, MSN, CRNP Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 12, 2021 Expired: No longer available for credit

In this concise interactive module, learn from experts about emerging therapeutic regimens for advanced melanoma, including tumor-infiltrating lymphocytes, intratumorally administered agents, and targeted therapy combinations.

Evan J. Lipson, MD Megan Schollenberger, MSN, CRNP Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 19, 2021 Expired: No longer available for credit

In this concise interactive module, learn how melanoma experts apply current treatment algorithms in multiple settings, including adjuvant therapy and unresectable or metastatic disease.

Evan J. Lipson, MD Megan Schollenberger, MSN, CRNP Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 26, 2021 Expired: No longer available for credit